Filed under: adrenal crisis, Cushing's, Myths and Facts | Tagged: adrenal crisis, adrenal insufficiency, cortisol, Hormone, Myths and Facts, steroid, stress, trauma | Leave a comment »
Myth: YOU are the problem and the reason for your cortisol levels…
#1 ~ Cushing’s Myths and Facts
Myth: “Cushing’s is RARE”, “No one has Cushing’s!”, “It is literally impossible for you to have Cushing’s Disease!”
Fact: We have all been guilty of referring to Cushing’s as a “Rare” disease. I*, myself, say this all the time. In fact, the statistics state that only about 2 in every million people are afflicted with this disease. However, these are documented cases.
In reality, Cushing’s is not as rare as we once thought. The fact is that Cushing’s is just rarely diagnosed! Non experts tend to not test accurately and adequately for Cushing’s.
With an inappropriate protocol for testing, the prevalence of accurate diagnoses decreases. Cushing’s experts DO understand how extensive and difficult the diagnostic process is, so they tend to be more deliberate and thorough when exploring possible Cushing’s in their patients. Cushing’s patients who cycle also have to be more persistent in asking for adequate testing so that they are appropriately diagnosed.
The following video is an accurate portrayal of what many patients experience when trying to get help for their symptoms:
Please review the following links:
http://home.comcast.net/~staticnrg/Cushings/LimitationsSC_UFC_dex_mildCS.pdf
http://survivethejourney.blogspot.com/2008/11/new-research-has-shown-cushings.html
Filed under: Cushing's, Myths and Facts, Video | Tagged: Cyclical Cushing's, Dr. Karen Ternier Thames, Myths and Facts, rare, testing, video | Leave a comment »
Cushing’s Myths and Facts
Dr. Karen Thames has been sharing these on her Facebook Page, Battleground Diagnosis: The War to Survive Cushing’s Disease.
She has graciously given me permission to share them here and in the CushieWiki and on the Cushing’s Help message boards.
Find these pages here, under the Myths and Facts category.
Thanks, Karen!
Filed under: Cushing's, Myths and Facts | Tagged: Cushing's, Myths and Facts | Leave a comment »
What Causes Overweight and Obesity?
Health Conditions
Some hormone problems may cause overweight and obesity, such as underactive thyroid (hypothyroidism), Cushing’s syndrome, and polycystic ovarian syndrome (PCOS).
Underactive thyroid is a condition in which the thyroid gland doesn’t make enough thyroid hormone. Lack of thyroid hormone will slow down your metabolism and cause weight gain. You’ll also feel tired and weak.
Cushing’s syndrome is a condition in which the body’s adrenal glands make too much of the hormone cortisol. Cushing’s syndrome also can develop if a person takes high doses of certain medicines, such as prednisone, for long periods.
People who have Cushing’s syndrome gain weight, have upper-body obesity, a rounded face, fat around the neck, and thin arms and legs.
PCOS is a condition that affects about 5–10 percent of women of childbearing age. Women who have PCOS often are obese, have excess hair growth, and have reproductive problems and other health issues. These problems are caused by high levels of hormones called androgens.
Read the entire article at http://www.nhlbi.nih.gov/health/health-topics/topics/obe/causes
Filed under: adrenal, Cushing's, pituitary, Rare Diseases | Tagged: adrenal, androgen, buffalo hump, cortisol, Cushing's Syndrome, hirsuitism, hypothyroidism, moonface, obesity, overweight, PCOS, Polycystic ovary syndrome, prednisone, thyroid, weight | Leave a comment »
Research Study: An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing’s Syndrome
Objectives:
The purpose of this study is to test the effects of different doses of COR-003 on people with Cushing’s syndrome (CS) primarily by measuring the cortisol levels in urine and secondarily by measuring other health parameters such as blood pressure, weight, and liver function. This study is also being conducted to see if there is any harm caused when using COR-003.
This study is an open label study. That means both the health providers and the participants in the study are aware of the drug or treatment being given.
Eligibility:
Adult Subjects (18 years or older) with elevated levels of cortisol due to endogenous CS.
Confirmed diagnosis of persistent or recurrent CS (with or without therapy) or newly diagnosed disease, if subjects are not candidates for surgery. CS will be defined according to the criteria in the guidelines for diagnosis of CS (Nieman 2008).
Women who are pregnant or lactating are not eligible for this study.
Individuals with other health conditions or diagnoses may not be eligible for this study.
These and other eligibility criteria are best reviewed with a doctor who is participating in the study. You can also get more detailed eligibility information about the study by clicking here to visit http://www.clinicaltrials.gov.
Study Design:
- The study will begin with a screening period to make sure subjects are eligible to participate in the study.
- After the screening period, subjects who are eligible for participation will each be given several different doses of COR-003, to be taken orally in tablet form.
- After an individualized dose has been selected, participants will take COR-003 for six months.
- Finally, participants will continue in the study for an additional six months at doses to be determined by the study doctor.
Throughout the study, participants will meet regularly with a study doctor and will take part in a variety of medical tests to make sure they are doing well and to see if COR-003 is working.
Participants in the study should be sure they have the time to participate. Participants will generally be followed for over a year:
Study Locations
The study is currently taking place in several places around the world (United States, Belgium, France, Israel, Netherlands, Spain, and Sweden).
Additional information on the study can be found at clinicaltrials.gov through this link.
Study sponsor: Cortendo AB
For more information, please contact:
Jim Ellis at Cortendo AB tel: +1 (610) 254-9245 or jellis@cortendo.com
Filed under: adrenal, Clinical trials, Cushing's, pituitary, Treatments | Tagged: 4R-ketoconazole, blood pressure, clinical trial, COR-003, Cortendo, Cortendo AB, cortisol, Cushing's Syndrome, endogenous, ketoconazole, liver, research, urine, weight | Leave a comment »

